Contact Us

OCREVUS® Infusion Therapy

Download Referral Form

OCREVUS infusion therapy is an IV medication administered as a treatment for Multiple Sclerosis (MS). OCREVUS infusion therapy may help prevent relapses in patients with MS or slow disease progression and improve daily life.

About OCREVUS® Infusion Therapy

OCREVUS infusion therapy (ocrelizumab) is an IV therapy used to treat patients with both Relapsing MS (RMS) and Primary Progressive MS (PPMS). OCREVUS is a biologic medication and contains proteins that target specific areas of the immune system.

In people with Multiple Sclerosis, the immune system inappropriately attacks the sheath that covers nerves in the brain and spinal cord. This sheath is called Myelin, and when it is damaged it causes disruptions in the communication signals sent throughout the body. The current understanding of this process is that B cells play a key role in triggering these attacks.

OCREVUS infusion therapy targets B cells and attaches to the B cells and destroys them before they can cause damage to the nerves.

OCREVUS® Infusion Therapy for MS

OCREVUS infusion therapy was approved by the FDA in 2017 to treat patients with Relapsing MS (RMS) and Primary Progressive MS (PPMS). It is the first medication approved to treat PPMS. Unlike other medications for MS that need to be administered more frequently, patients receiving OCREVUS infusions only require 3 infusions in the first year of treatment.

In a clinical study, about 83% of OCREVUS patients with RMS had no relapses, while the number of total relapses was cut almost in half (46%).1 OCREVUS infusion therapy patients with PPMS were shown to be 24% less likely to have disability progression while on the medication. This means patients were 24% less likely to notice worsening MS symptoms, including numbness, loss of coordination, speech and swallowing problems, memory loss, visual impairment, and bowel and bladder dysfunction, and muscle weakness.

OCREVUS® Cost

The out-of-pocket OCREVUS cost will vary depending on your insurance coverage. If you have Medicare Part B or Medicaid, some of the OCREVUS cost may be partially covered. 

Patients with commercial insurance may qualify for the OCREVUS Co-pay Program which can help cover the OCREVUS cost. For more information on OCREVUS cost and financial resources, you may visit https://www.ocrevus.com/patient/financial-support/assistance-options.html. 

No patient should go without necessary treatment due to financial limitations. If you have questions about financial assistance opportunities or OCREVUS cost, contact a member of our FlexCare team or your referring provider.

What to Expect During OCREVUS® Infusion Therapy 

If your provider has prescribed OCREVUS infusion therapy as a Multiple Sclerosis medication, you will receive 2 doses six months apart. The first dose of OCREVUS is administered as 2 infusions that last around 2.5 hours. Your MS infusion may take longer depending on a variety of factors.

OCREVUS Side Effects

Most patients tolerate OCREVUS well. The most commonly reported OCREVUS side effects include skin and upper respiratory tract infections and infusion reactions (itching, redness, headache, nausea, throat irritation, fatigue, and dizziness).

There is a possibility of Hepatitis B reactivation during OCREVUS treatment. Before starting OCREVUS, your provider will perform a Hepatitis B screening to rule out active HBV. If you have had HBV in the past, your provider will monitor your risk throughout your course of treatment.

If you have concerns about OCREVUS side effects, contact your referring provider.

OCREVUS Infusion Therapy at FlexCare

Before your OCREVUS infusion, it’s important to take care of your overall health. Prepare for your visit to have a more comfortable infusion experience. It’s recommended to wear comfortable clothes and a shirt with loose-fitting sleeves. Make sure to arrange for transportation in advance and bring any needed items, such as your laptop or phone, with you to your appointment.

Find an infusion center near you.

Getting Started With Infusion Therapy

If you have Relapsing or Primary Progressive MS, talk with your provider about an OCREVUS infusion therapy referral for FlexCare Infusion Centers. We offer convenient evening and weekend appointment times, comfortable infusion suites, and walk-up parking for OCREVUS patients.

If you have any questions, you can also contact FlexCare directly. We look forward to helping you soon.

Send Us a Referral
Questions? Contact Us

Have Questions?

If you have any questions about OCREVUS or infusion therapy, contact us directly. We look forward to helping you on your journey to better health.

Contact Us
Aaron Smith named Entrepreneur of the Year Southwest Award finalist

Aaron Smith partnered with Callie Turk to start FlexCare Infusion Centers after learning firsthand the profound impact specialty infusion can have on patients and the challenges they often encounter on the journey to effective treatment. There is an unprecedented opportunity to improve access, delivery, and outcomes through better communication, technology, and operations. At FlexCare Infusion Centers, his team works hard to make the changes the patients deserve to see.

Aaron joined the healthcare sector 25 years ago when he co-founded a disease management software company focused on patient outcomes collection and ambulatory clinic accreditation. He entered population health through an acquisition of Healthways and later entered specialty medications with Briova – an Optum company. His FlexCare team routinely makes the impossible possible through expertise, good process, cutting edge technology, data-driven decision making, and a lot of listening.

Makenna joined FlexCare in 2021 as the Managing Nurse Practitioner in Birmingham. In 2023, she assumed the role of National Director of Clinical Services. Makenna oversees protocol optimization, patient safety, and clinical procedures.

Makenna holds an MSN and FNP-C certification from Samford University. Previously, Makenna worked as an ENT nurse before earning her certification from the American Academy of Nurse Practitioners (AANP) in 2018.

Makenna is married to Wes, and together they have two cats, Ralphie and Beans. She enjoys going to concerts, trying new restaurants, playing trivia and board games with friends, and has recently taken up skateboarding as a hobby.

Heather joined FlexCare in 2020 and led the development of the Intake team before taking over Revenue Cycle Management in 2022. Heather has 10 years of medical RCM experience in ambulatory, specialty pharmacy, and home infusion. Previously, Heather was the Assistance Director of RCM in Intake for a Specialty Pharmacy and Home Infusion service in Kansas. 

Currently, Heather oversees RCM for FlexCare’s ambulatory infusion services and specialty pharmacy. She lives in Olathe, KS with her husband and two children.

Rebekkah joined FlexCare Infusion Centers in 2019 as a Managing Nurse Practitioner and Specialty Biologics Clinical Reviewer before assuming the role of Director of Patient Access in 2022. Rebekkah heads FlexCare’s industry-leading Intake team and ensures FlexCare patients experience the shortest time to treatment.

Rebekkah graduated from the University of Oklahoma Health Sciences Center where she earned her Master of Science Degree in Nursing with a Family Nurse Practitioner emphasis. She has over 16 years of experience in patient care and is passionate about infusion therapy and best serving our patients.

Rebekkah lives in Oklahoma City with her 3 kids and her dog. When she’s not keeping busy with her kids, you can find her in her craft room.

Matt is an acute care Nurse Practitioner with over a decade of committed service to the patients in his community. Matt joined FlexCare in 2021 as a Managing Nurse Practitioner and led the launch of the first FlexCare location in Alabama before assuming the role of Vice President of Operations in 2023.

Matt received his BSN from Auburn University before earning his MSN from Vanderbilt University. His experience includes Intensive Care, Transplant Medicine, Cardiothoracic Surgery, and Outpatient Care. Prior to joining FlexCare, Matt developed and launched two new service lines for an outpatient cardiology group in Alabama.

Matt and his wife Rachel reside in Birmingham, AL with their two pets, Addie and Jenkins.

Austin joined FlexCare in 2020 as a software consultant before assuming the role of Vice President of Technology in 2021. He led the initiative to build a custom-developed enterprise software solution that supports and enhances FlexCare’s vital Intake team, and later led the projects to create data and reporting systems to support all departments. He oversees FlexCare’s software, data, IT, and communications projects.

Austin graduated from the University of Oklahoma with a degree in mechanical engineering. His focus on electromechanical systems quickly led to a passion for automation and building software and data solutions. After gaining experience as a software and applications engineer, he started a software consulting company and has launched several enterprise web, desktop, and mobile applications.

Austin lives in Oklahoma City with his wife, Skye, and two kids. In his free time, you can find him on the running trail, golf course, or playing games and sports with his family and friends.

Rick’s professional trajectory took him into leadership just 3 years after obtaining his Doctor of Pharmacy (Pharm.D.) from the University of Arizona. His desire to be a business leader in the world of pharmaceuticals and operations drove him to complete two post-graduate residencies in Milwaukee, WI, with a heavy concentration on administration leadership.  Rick was selected to represent the state of Wisconsin in a joint venture with the state of Iowa at the 2007 Young Pharmacy Leaders Conference.  

After a successful launch to his career in Milwaukee, WI, Rick returned to Arizona to be closer to his extended family.  In Arizona, he oversaw all pharmaceutical operations of the hospital-based outpatient clinics at HonorHealth, where he met his future business partner, Mark Kharoufeh.  Rick and Mark co-founded InfuseAble Care in Scottsdale, AZ, in 2020.  When FlexCare acquired InfuseAble Care in 2021, Rick transitioned to EVP of Pharmacy, leading the supply chain and procurement initiatives across the enterprise.  With the recent acquisition of a specialty pharmacy, Rick extended his purview to include oversight of this valuable service line.

Rick currently resides in Scottsdale, AZ with his wife.  His son attends Northern Arizona University in Flagstaff, AZ.

Mark began his journey in healthcare almost 30 years ago as a pediatric oncology nurse at Los Angeles Children’s Hospital. His evolution in healthcare through various clinical, leadership, and executive roles and a passion for customer service led him down a successful path of business operations. In 2012, Mark was a finalist for AZ Business Magazine’s “Healthcare Professional of the Year” for his leadership in an all-inclusive care under one roof ambulatory healthcare service model. Mark obtained his MBA from Grand Canyon University in 2015 and completed the University of Arizona Eller Executive Leadership Program in 2019. 

Mark’s dedication to enhancing access to healthcare and a model that always places the patients and their caregivers at the center of every visit was the impetus for teaming up with Rick Yerondopoulos and establishing InfuseAble Care in November 2020. Through Mark and Rick’s reputation in Arizona for reliable and service-oriented healthcare, InfuseAble Care’s brand quickly became the trusted ambulatory infusion center for physicians to refer their patients to around the state. Mark and Ricks’s goals of scaling InfuseAble Care nationally came to fruition upon meeting Aaron Smith, Callie Turk, and Adam Midkiff of FlexCare and RC Capital and ultimately joined FlexCare Infusion via acquisition in December 2021.

Since uniting with FlexCare to provide a reimagined infusion experience across the country, FlexCare has grown to 30 ambulatory centers across three states.

Mark currently resides in Litchfield Park, AZ with his wife, two sons, daughter, and labradoodle Eevee. 

Adam joined FlexCare in 2023, though he has been involved with the organization from the early stages. He is excited by FlexCare’s mission to provide better access and high-quality care to patients in cost appropriate settings. Prior to joining FlexCare, Adam was a private equity investor with RC Capital, and he helped architect the partnership between FlexCare and RC. Prior to Adam’s experience in healthcare private equity, he was an investment banker in New York City and involved in numerous M&A and capital raising transactions.

Adam currently resides in Cincinnati, OH with his wife and two kids. He serves on the board of the Cincinnati Healthcare Professionals Network, a group of healthcare leaders with a common goal to advance healthcare innovation within the Cincinnati ecosystem. He graduated from the University of Kentucky with a degree in finance. In his spare time, Adam can be found on a soccer field or a golf course.

Jack joined FlexCare in 2023, after most recently serving as CFO and COO of Lighthouse Behavioral Health Solutions in Central Ohio. Lighthouse focuses on improving the lives of those suffering from substance abuse disorder by combining a suite of services in an outpatient setting along with recovery housing. Prior to Lighthouse, Jack had stints in corporate accounting and finance roles at PricewaterhouseCoopers, Omnicare, and Procter & Gamble. Additionally, he embarked on an entrepreneurial journey over the last decade, beginning with a hospitality business that has grown from a single, urban sports bar to 8 bar, restaurant, and brewery locations opened in 10 years. He also opened and sold a boutique fitness studio.

Jack graduated from Miami University with bachelor’s and master’s degrees in accounting. He resides in Cincinnati, OH, where he can often be found on the golf course or trying to stay active by chasing around his young kids with his wife, Anna.